Delta Pharma

Events

Events

News

Pharmacological treatments play a vital role in managing Autism Spectrum Disorder (ASD), aiming to alleviate symptoms and enhance the quality of life for individuals on the spectrum. Recent developments in this field have seen significant progress, offering new hope and opportunities for improved therapeutic interventions.

According to clinical trials it offers protection up to 90%.

The American company “Pfizer” and the German “BioNTech” have made possible for the first time the efficient production of an anti-covid vaccine.

 

The British regulator, MHRA, says the vaccine, which offers up to 95% protection against Covid-19, is safe to use.

Immunizations can be started within a few days for people and high-risk groups.

 

Regulators in the UK have given approval for emergency use to the vaccine developed by the University of Oxford and the company AstraZeneca.

In a statement, the UK government said the Regulatory Agency for Drugs and Health Products (MHRA) had authorized the University of Oxford / AstraZeneca vaccine Covid-19 following “rigorous clinical trials and a thorough analysis of data by MHRA experts” “.

During January/February it was recorded a high number, not only of positive cases with Covid, but also a high number of deaths. This showed that the country went through a second wave of the pandemic.

 

Following the Sputnik vaccine, the EMA is also reviewing the Chinese coronavirus vaccine, Sinovac. Initial data from laboratory studies show that according to the EMA this vaccine does produce an immune response. 

 

The World Health Organization (WHO) has granted emergency approval for the Covid vaccine made by Chinese state-owned company Sinopharm.

It is the first vaccine developed by a non-Western country to get WHO backing. The vaccine has already been given to millions of people in China and elsewhere.

Videos

[Rich_Web_Video id="1"]